Stay updated on Comparison of Treatments for TFE/tRCC Clinical Trial
Sign up to get notified when there's something new on the Comparison of Treatments for TFE/tRCC Clinical Trial page.

Latest updates to the Comparison of Treatments for TFE/tRCC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe Locations section was refreshed from revision v3.3.2 to v3.3.3, consolidating location data under a single Locations entry and removing the previous state-specific blocks.SummaryDifference1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedUF Health Cancer Institute - Gainesville was added as a participating site, and University of Florida Health Science Center - Gainesville was removed from the study locations.SummaryDifference0.1%

- Check37 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1.SummaryDifference0.0%

- Check51 days agoChange DetectedStudy locations updated to 269 sites. New centers added include CommonSpirit Cancer Center Mercy, Rush MD Anderson Cancer Center, Oncology Las Vegas - Henderson, and Oncology Las Vegas - Tenaya; several former sites were removed (GenesisCare USA Fort Apache, GenesisCare USA Henderson, GenesisCare USA Vegas Tenaya, Rush University Medical Center), reducing total sites from 271.SummaryDifference0.3%

- Check66 days agoChange DetectedResults section added with study outcomes and the 'Results First Posted' date (2025-10-10). Outcome measures such as progression-free survival, overall survival, and objective response rate are now described on the page.SummaryDifference0.1%

Stay in the know with updates to Comparison of Treatments for TFE/tRCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparison of Treatments for TFE/tRCC Clinical Trial page.